Lite Strategy, Inc. Contract with Customer, Performance Obligation Satisfied in Previous Period
Lite Strategy, Inc. (LITS) reported Contract with Customer, Performance Obligation Satisfied in Previous Period of $19.00 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Revenue from Contract with Customer
us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod · last filed 2020-11-10
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-09-30 was $19.00M, a 413.51% increase year-over-year.
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-06-30 was $12.30M, a 1437.50% increase year-over-year.
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2020-03-31 was -$600.00K, a 400.00% decline year-over-year.
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for the quarter ending 2019-12-31 was -$600.00K.
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2020 was $14.80M, a 196.00% increase from fiscal 2019.
- Lite Strategy, Inc. contract with customer, performance obligation satisfied in previous period for fiscal 2019 was $5.00M.
| Period end | Contract with Customer, Performance Obligation Satisfied in Previous Period 3 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 6 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 9 month | Contract with Customer, Performance Obligation Satisfied in Previous Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | $19.00M 10-Q · filed 2020-11-10 | $31.30M derived: sum of 2 quarters · filed 2020-11-10 | $30.70M derived: sum of 3 quarters · filed 2020-11-10 | $30.10M derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | $12.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-09 | $11.70M derived: sum of 2 quarters · filed 2020-09-09 | $11.10M derived: sum of 3 quarters · filed 2020-09-09 | $14.80M 10-K · filed 2020-09-09 |
| 2020-03-31 | -$600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-07 | -$1.20M derived: sum of 2 quarters · filed 2020-05-07 | $2.50M 10-Q · filed 2020-05-07 | $3.30M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | -$600.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | $3.10M 10-Q · filed 2020-02-06 | $3.90M derived: sum of 3 quarters · filed 2020-02-06 | $4.10M derived: sum of 4 quarters · filed 2020-02-06 |
| 2019-09-30 | $3.70M 10-Q · filed 2019-11-07 | $4.50M derived: sum of 2 quarters · filed 2019-11-07 | $4.70M derived: sum of 3 quarters · filed 2019-11-07 | |
| 2019-06-30 | $800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-28 | $1.00M derived: sum of 2 quarters · filed 2019-08-28 | $5.00M 10-K · filed 2019-08-28 | |
| 2019-03-31 | $200.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-09 | $4.20M 10-Q · filed 2019-05-09 | ||
| 2018-12-31 | $4.00M 10-Q · filed 2019-02-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |